SPONSOR
Nanjing Medical University
Total Trials
7
Recruiting
7
Phases
Phase 3
Conditions studied: Type 1 DiabetesAortic DissectionSystemic Inflammatory Response SyndromeCardiovascular Diseases (CVD)Obstructive Sleep ApneaHypertensionHealth BehaviorPublic HealthAcute Aortic SyndromeAortic Dissection Type a
Nanjing Medical University is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Type 1 Diabetes, Aortic Dissection, Systemic Inflammatory Response Syndrome, Cardiovascular Diseases (CVD).
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Nanjing Medical University
How many clinical trials has Nanjing Medical University sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by Nanjing Medical University, of which 7 are actively recruiting participants. These trials cover conditions including Type 1 Diabetes, Aortic Dissection, Systemic Inflammatory Response Syndrome. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Nanjing Medical University research focus on?
Nanjing Medical University clinical trials span Type 1 Diabetes, Aortic Dissection, Systemic Inflammatory Response Syndrome, Cardiovascular Diseases (CVD), Obstructive Sleep Apnea, and additional conditions. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Nanjing Medical University clinical trial?
To participate in a Nanjing Medical University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Nanjing Medical University trials with current recruitment status updated daily.
Clinical Trials by Nanjing Medical University
NCT07258394 Phase 3
Recruiting
Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus
Type 1 Diabetes
NCT06195267
Recruiting
Protective Effect of Sivelestat Against Negative Pulmonary Function and Organ Dysfunction After Cardiovascular Surgery (PANDA VI)
Aortic Dissection
NCT07003399
Recruiting
Diaphragmatic Function and Respiratory Drive in OSA and COPD
Obstructive Sleep Apnea
NCT06640751
Recruiting
The Effect of Interventions for Health Behaviors in Hypertensive Patients
Hypertension
NCT05339529
Recruiting
Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)
Acute Aortic Syndrome
NCT04398992
Recruiting
Additive Anti-inflammatory Action for Aortopathy & Arteriopathy
Acute Aortic Syndrome
NCT07565402
Recruiting
Effects and Mechanisms of Transcranial Direct Current Stimulation Combined With Dialectical Behavior Therapy Skills Training in Adults With Attention-Deficit/Hyperactivity Disorder
Adult Attention Deficit Hyperactivity Disorder
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology